MAPK3 and dermatitis: Previous reports analyzing the effect of a marine diterpenoid of the briarane family in an in vivo model of TPA-induced dermatitis also demonstrated a selective inhibitory effect on NFκB activation with no interference with ERK1/2 activation [15].